P138 Time trends for incidence and survival of epithelial ovarian, fallopian tube, peritoneal and undesignated site cancer in sweden 1960–2014 – a population-based survey of cancer registry data

Author(s):  
P Leandersson ◽  
T Högberg ◽  
P Dickman ◽  
S Malander ◽  
C Borgfeldt
2015 ◽  
Vol 6 (4) ◽  
pp. 427-434 ◽  
Author(s):  
Meesha Chaturvedi ◽  
K. Vaitheeswaran ◽  
K. Satishkumar ◽  
Priyanka Das ◽  
S. Stephen ◽  
...  

2006 ◽  
Vol 15 (2) ◽  
pp. 165-170 ◽  
Author(s):  
Andreas Stang ◽  
Andrea Schmidt-Pokrzywniak ◽  
Martin Lehnert ◽  
Donald M. Parkin ◽  
Jaques Ferlay ◽  
...  

2020 ◽  
Vol 31 ◽  
pp. S398
Author(s):  
F. Giusti ◽  
M.D.C. Martos ◽  
S. Scoccianti ◽  
L. Neamtiu ◽  
G. Randi ◽  
...  

PLoS ONE ◽  
2020 ◽  
Vol 15 (1) ◽  
pp. e0228551 ◽  
Author(s):  
Nina Afshar ◽  
Dallas R. English ◽  
Tony Blakely ◽  
Vicky Thursfield ◽  
Helen Farrugia ◽  
...  

2017 ◽  
Vol 35 (15_suppl) ◽  
pp. e13058-e13058
Author(s):  
Klaus Pietzner ◽  
Nina Buttmann ◽  
Jalid Sehouli ◽  
Klaus Kraywinkel

e13058 Background: Sarcoma of the female genital tract are rare tumors. They are described to be associated with a poor prognosis, when compared to gynecogical carcinoma. Aim of this study was to report incidence patterns and survival rates for gynecological sarcoma in Germany. Methods: Clinical data and survival rates for patients with gynecological sarcoma diagnosed in Germany between 2009 and 2013 were extracted from the German national centre for population-based cancer registry data. Incidence patterns and 5-year-relative survival rates were calculated. Results: A total of 2,106 gynecological sarcoma (GS) were eligible for analysis. The uterus was the most common site with 87.2% of all cases. The annual age-standardized incidence rate was 7.7 per 1 million women for all gynecological sarcoma. The median age at diagnosis was 59 years. The prognosis ranged according to site and subtype from a poor 5-year-relative survival of 47.6% (uterine leiomyosarcoma) to a very good 5-year-relative survival of 97.2% (endometrial stromal sarcoma). Conclusions: Despite the rareness of gynecological sarcoma, the size of the dataset allows a differentiation of subtypes according to morphology and site of origin. Clinically relevant differences in incidence and prognosis between subgroups were observed.


Sign in / Sign up

Export Citation Format

Share Document